Response to Pembrolizumab in a Heavily Treated Patient With Metastatic Ovarian Carcinosarcoma

Gynecologic Oncology Research and Practice
doi 10.1186/s40661-018-0063-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

An Uncommon Response to Metronomic Therapy in a Heavily Pretreated Patient With Metastatic Carcinosarcoma: A Case Report

Journal of Medical Case Reports
Medicine
2016English

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

Pembrolizumab in a Patient With a Metastatic CASTLE Tumor of the Parotid

Frontiers in Oncology
Cancer ResearchOncology
2019English

Single Case of a Complete Response in a Metastatic Urothelial Carcinoma Patient Treated With Zoptarelin Doxorubicin

European Oncology and Haematology
OncologyHematology
2014English

Uterine Carcinosarcoma in a Patient With Didelphys Uterus

Case Reports in Obstetrics and Gynecology
2013English

Response to Nab-Paclitaxel and Nedaplatin in a Heavily-Metastatic Thymic Carcinoma: A Case Report

Oncology Letters
Cancer ResearchOncology
2015English

Clinical Response in Patients With Ovarian Cancer Treated With

ecancermedicalscience
Cancer ResearchOncology
2017English

Talimogene Laherparepvec in Combination With Pembrolizumab Leads to a Complete Response in a Patient With Refractory Merkel Cell Carcinoma

JAAD Case Reports
Dermatology
2018English

Correction To: Prolonged Stable Disease in a Uveal Melanoma Patient With Germline MBD4 Nonsense Mutation Treated With Pembrolizumab and Ipilimumab

Immunogenetics
ImmunologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy